Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CTRB1 | P17538 | 2/20 | 0.54 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.53 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.53 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.52 |
| ▸ | FOLH1 | Q04609 | 2/20 | 0.49 |
| ▸ | LMNA | P02545 | 2/20 | 0.49 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.49 |
| ▸ | HTT | P42858 | 2/20 | 0.48 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.48 |
| ▸ | FNTA | P49354 | 1/20 | 0.48 |
| ▸ | FNTB | P49356 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31265234 | 0.88 | CASP1 (0.54) | MAPK1ALDH1A1FOLH1HTT | |
| SCHEMBL330061 | 0.88 | CTSL (0.55) | CTRB1ALDH1A1 | |
| SCHEMBL8976911 | 0.88 | CTSL (0.55) | CTRB1ALDH1A1 | |
| SCHEMBL5486969 | 0.88 | CTSL (0.55) | CTRB1ALDH1A1 | |
| SCHEMBL2416694 | 0.86 | CTRB1 (0.67) | CTRB1ALDH1A1FNTAFNTB | |
| SCHEMBL9544107 | 0.86 | CTRB1 (0.67) | CTRB1ALDH1A1FNTAFNTB | |
| SCHEMBL6568131 | 0.86 | CTRB1 (0.67) | CTRB1ALDH1A1FNTAFNTB | |
| SCHEMBL11239042 | 0.86 | CTSL (0.53) | CTRB1ALDH1A1 | |
| SCHEMBL31488862 | 0.86 | ALDH1A1 (0.51) | MAPK1CYP3A4ALDH1A1FOLH1LMNA | |
| SCHEMBL16485550 | 0.86 | CTSL (0.53) | CTRB1ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-112638934-B | Solution phase Path for WNT hexapeptide | 温特研究公司 | 2024-06-11 | — | — | CN | disclosed |
| US-11970551-B2 | Solution phase routes for WNT hexapeptides | WNTRESEARCH AB (SE) | 2024-04-30 | — | — | US | disclosed |
| US-11912791-B2 | Solution phase routes for Wnt hexapeptides | WNTRESEARCH AB (SE) | 2024-02-27 | — | — | US | disclosed |
| US-20230295232-A1 | SOLUTION PHASE ROUTES FOR WNT HEXAPEPTIDES | WNTRESEARCH AB (SE) | 2023-09-21 | — | — | US | disclosed |
| EP-3841107-B1 | SOLUTION PHASE ROUTES FOR WNT HEXAPEPTIDES | WNTRESEARCH AB (SE) | 2023-06-28 | — | — | EP | disclosed |